|
|
Cell Genesys Stock Price CEGECompany Description : A biotechnology company focused on the development and commercialization of novel biological therapies for patients with cancer. url: www.cellgenesys.com |
Name:
Cell Genesys (MM) |
Symbol:
NASDAQ:CEGE |
Stock Market:
NASDAQ Stock Market |
Type:
Common Stock |
ISIN:
|
Description:
|
| | Change (p) | Change (%) | Cur | Bid | Ask | High | Low | Open | Volume | Time | A | |  | | | | | | | | | | | | |
 Register for free Cell Genesys stock prices. |
BeaconEquity.com Issues TraderNotes on Active Stocks: SWHC, ARNA, BORL, QTWW, CSGH, FEED, BVN, CEGE : DALLAS, June 27 /PRNewswire/ -- BeaconEquity.com announces the availability of TraderNotes on stocks that are making news today.
Investors can view all of the daily trading notes for free by visiting:
http://www.beaconequity.com/m
Today's... Free Cell Genesys Stock Charts
Cell Genesys Historical Stock Chart
 |
| Cell Genesys Monthly Stock Chart
 | Cell Genesys Intraday stock chart
 | Register for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range. Get the Latest Cell Genesys stock Price, quotes, trades and FREE Cell Genesys stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Cell Genesys (CEGE) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards. | | Cell Genesys News
| Latest Cell Genesys News Headlines | | Date | Time | Source | | | 06/27/2008 | 10:00AM | PRNUS | BeaconEquity.com Issues TraderNotes on Active Stocks: SWHC, ARNA, BORL, QTWW, CSGH, FEED, BVN, CEGE |
| 04/23/2008 | 7:00AM | PRNUS | Ceregene Announces Two Key Additions to Leadership Team |
| 04/11/2008 | 9:23AM | TFNF | Cell Genesys: Statistically significant results for GVAX immunotherapy |
| 04/01/2008 | 8:56AM | TFNF | Cell Genesys shares jump premarket; JPMorgan reiterates neutral rating |
| 03/11/2008 | 8:30AM | PRNUS | Cell Genesys to Present at the Cowen and Company and the Lehman Brothers Healthcare Investor Conferences |
| 02/28/2008 | 7:00PM | TFNF | Cell Genesys 4Q net loss narrows |
| 02/28/2008 | 4:00PM | PRNUS | Cell Genesys Reports Fourth Quarter and Year-End 2007 Results |
| 02/21/2008 | 8:30AM | PRNUS | Cell Genesys to Webcast Fourth Quarter and Year-End 2007 Conference Call |
| 02/19/2008 | 9:49AM | PRNUS | BeaconEquity.com Issues TraderNotes on RMDX, CEGE, PCLN, BRCD, and CEM |
| 02/15/2008 | 8:30AM | PRNUS | Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostat |
| 02/04/2008 | 8:30AM | PRNUS | Cell Genesys to Present at the BIO CEO and Investor Conference |
| 01/14/2008 | 9:00AM | PRNUS | Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer |
| |
Cell Genesys Company Information| Sector | Turnover (m) | Profit (m) | EPS - Basic | PE ratio | Mkt Cap (m) | NMS | | | 0.00 | 0.00 | | | 0.0 | N/A |
| Register for FREE access to the latest Cell Genesys company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales. |
Latest Cell Genesys Stock Trade| Type | Size | Price | Date | Tr.Time | Units | | | | | | | USD |
|
|
| |